Company Filing History:
3 out of 1,863 
1 out of 504 
1 out of 1,270 
Years Active: 2022-2025
Title: Innovations and Contributions of Inventor Alexander Deiters
Introduction
Alexander Deiters is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of small molecule compounds and drug delivery systems. With a total of 3 patents, his work has implications for various therapeutic applications.
Latest Patents
One of his latest patents is focused on the small molecule inhibition of sulfotransferase SULT1A3. This patent provides small molecule compounds and methods for inhibiting human sulfotransferase 1A3 (SULT1A3), along with methods of manufacturing and treatment. Another significant patent involves boryl ethers, carbonates, and cyclic acetals as oxidatively-triggered drug delivery vehicles. This patent describes a compound or a pharmaceutically acceptable salt with a specific structure, which includes a cleavable linker group and a cargo moiety-containing group.
Career Highlights
Throughout his career, Alexander Deiters has worked with prestigious institutions such as the University of Pittsburgh and Albert Einstein College of Medicine. His research has focused on innovative approaches to drug development and delivery, showcasing his expertise in the field.
Collaborations
He has collaborated with notable colleagues, including Kristie E. Darrah and Mary Frances Cacace, contributing to a dynamic research environment that fosters innovation.
Conclusion
Alexander Deiters is a prominent inventor whose work in small molecule compounds and drug delivery systems has made a significant impact in pharmaceutical sciences. His patents reflect his commitment to advancing medical research and improving therapeutic options.